CurrentEndo
Get Weekly

Topic · page 35 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 1,361–1,367 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. J Clin Endocrinol Metab

    Twelve Loci Associated With Bone Density in Middle-aged and Elderly Chinese: The Shanghai Changfeng Study

    Research article

  2. J Clin Endocrinol Metab

    General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: Registry-Based Cohort Study

    Cohort study

  3. Osteoporos Int

    The relationship between sarcopenia-related measurements and osteoporosis: The SARCOP study

    Cross-sectional study

  4. Clin Endocrinol (Oxf)

    The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study

    Cohort study

  5. Clin Endocrinol (Oxf)

    Elevated bone turnover markers predict bone mineral density accrual in adolescents with 21‐hydroxylase deficiency

    Cohort study

  6. Clin Endocrinol (Oxf)

    Primary hyperparathyroidism in adults—(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society

    Guideline or statement

  7. Clin Endocrinol (Oxf)

    Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow‐up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society

    Guideline or statement

All 1,367 Briefs in ExploreShowing Briefs 1,361–1,367 of 1,367, newest first